TH178544A - Composition and method of application For enhanced immune response and cancer therapy - Google Patents

Composition and method of application For enhanced immune response and cancer therapy

Info

Publication number
TH178544A
TH178544A TH1701001953A TH1701001953A TH178544A TH 178544 A TH178544 A TH 178544A TH 1701001953 A TH1701001953 A TH 1701001953A TH 1701001953 A TH1701001953 A TH 1701001953A TH 178544 A TH178544 A TH 178544A
Authority
TH
Thailand
Prior art keywords
composition
application
immune response
cancer therapy
enhanced immune
Prior art date
Application number
TH1701001953A
Other languages
Thai (th)
Inventor
บร็อกดอน นางสาวเจนนิเฟอร์
ชิโพลเล็ตต้า นางสาวดาเนียลา
แดรนออฟ นางสาวเกล็นน์
เอ. นี นางสาวเดบราห์
หวัง นางสาวเฟย
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
นางสาวสุคนธ์ทิพย์ จิตมงคลทอง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์, นางสาวสุคนธ์ทิพย์ จิตมงคลทอง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH178544A publication Critical patent/TH178544A/en

Links

Abstract

สิทธิบัตรยา Drug patent

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แท็ก : สิทธิบัตรยา: Privilege (number one) that will appear on the advertisement page: Tag: drug patent
TH1701001953A 2015-10-08 Composition and method of application For enhanced immune response and cancer therapy TH178544A (en)

Publications (1)

Publication Number Publication Date
TH178544A true TH178544A (en) 2018-08-02

Family

ID=

Similar Documents

Publication Publication Date Title
TH178544A (en) Composition and method of application For enhanced immune response and cancer therapy
TH181796A (en) Angio-poitin-like-4 antibodies and methods of their use
TH1601006420A (en) The IGF-1R antibody and its use are referring to the drug for the treatment of cancer.
TH179122A (en) Antibodies against CLL-1 and immunoconjugated
TH179187A (en) Glycoconjugate Components for Immunosuppression / Therapy And using that
TH181128A (en) A new anti-MFI2 antibody and method of application
TH1701003010A (en) Components for the treatment of schizophrenia
TH182881A (en) Composition for use in the treatment of anaphylaxis
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH1601003539A (en) The conjugate of ANT-HER2 antibody-drug
TH1501005386A (en) "The iRNA component of the C5 component component and its use method"
TH175712A (en) High-efficiency radiation-induced stimulation for the elements. That formed as needed and methods of use
TH180433A (en) Compounds and elements for the induction of cartilage formation
TH179118A (en) Composition and method of cementing
TH1601007712A (en) Composition and use of such elements
TH169632A (en) Devices and methods for induction heating of cladding materials For making packaging
TH181291A (en) Peptidomatic compounds and conjugate antibodies - the drug of that
TH1701006100A (en) Pyridopyrimidenone and its use
TH1701007724A (en)
TH177015A (en) Pig parvovirus 5A method of use and vaccine
TH180317A (en) Melting component of the antisyrum albumin portion FAB-effects, and their preparation methods
TH1601000340A (en) Composition of a carbohydrate vaccine for the inducing immune response and its use in cancer treatment.
TH170275A (en) Methods of manufacturing soft enteric capsules
TH179638A (en) Antibodies against CD3 and how they are used
TH1701003631A (en) Quinazoline derivatives used to treat HIV